ECONOMIC ASPECTS OF APPLICATION OF THE RUSSIAN BIOSIMILAR OMALIZUMAB IN PATIENTS WITH ATOPIC BRONCHIAL ASTHMA OF MODERATE TO SEVERE CLINICAL COURSES

• Автори: V. S. Krysanova (Автор), E. D. Ermolaeva (Автор), T. N. Ermolaeva (Автор), M. V. Davydovskaya (Автор), K. A. Kokushkin (Автор)
• Формат: Книга
• Опубліковано: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute, 2021-08-01T00:00:00Z.
• Предмети: article
• Онлайн доступ: Connect to this object online.

A certain success in the treatment of bronchial asthma is associated with the introduction of monoclonal antibodies into the treatment process. They made it possible to improve the control of the disease. A number of original genetically engineered biological drugs, such as benralizumab, reslizumab,...